Studies that have focused on CBD for trigeminal neuralgia have concluded that either the CB1 receptor alone or a combination of both the CB1 and the CB2 receptors are responsible for the antineuralgia effects of cannabinoids. There is a growing body of evidence to suggest that CB2 receptor activation alone might be enough to produce cannabinoid mediated antineuralgia effects. A new CB2 receptor agonist was found to effectively reduce pain in rat models of neuropathic pain and three other types of pain without significantly effecting motor skills. In both animal tests and anecdotally in humans, many people feel cannabinoids have proven effective treatments in the management of trigeminal neuralgia.
For anyone suffering from this horrific disorder, desperation is real and most patients are willing to give ANYTHING a shot. Many people have hopped on the band wagon of CBD and are trying it out for themselves, basking in the success. It is time for anyone living with TN to get some relief from this extremely painful disorder and start enjoying life again.